by Asa Elmore | Apr 20, 2021 | News, Press Releases
Sutro Biopharma Promotes Trevor Hallam, Ph.D., to President of Research and Chief Scientific Officer SOUTH SAN FRANCISCO, Calif., April 20, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on...
by Asa Elmore | Apr 15, 2021 | Events, News, Presentations
20th Annual Needham Virtual Healthcare Conference – Presentation Webcast, Click Here Download Presentation, Click...
by Asa Elmore | Apr 15, 2021 | News, Press Releases
Sutro Biopharma Earns Milestone Payment from Cytokine Derivatives Collaboration with Merck – Initiation of an IND enabling toxicology study for the first program under the 2018 collaboration oncytokine derivatives earns a $15 million milestone payment from Merck...
by Asa Elmore | Apr 14, 2021 | Careers
Senior Accountant Sutro has a unique capability that enables new molecular entities to be designed using a hybrid of synthetic and recombinant technologies to create best in class therapeutics in the oncology and auto-immune disease space. Our portfolio includes...
by Asa Elmore | Apr 13, 2021 | Careers
Scientist, Chemistry Sutro has a unique capability that enables new molecular entities to be designed using a hybrid of synthetic and recombinant technologies to create best in class therapeutics in the oncology and auto-immune disease space. Our portfolio includes...
